Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
11/2000
11/09/2000CA2368801A1 Conjugates as therapies for cancer and prostate diseases
11/08/2000EP1049664A1 Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
11/08/2000EP1049662A1 Inhibitors of alpha4 mediated cell adhesion
11/08/2000EP0862550B1 Carboxylic acid derivatives, their preparation and their use
11/08/2000CN1272840A Novel vitamin D derivatives with cyclopropyl rings in lateral chains, its production method and intermediate and utilization thereof for producing medicaments
11/08/2000CN1058262C Novel 1-phenylalkanone 5-HT4 receptor ligands
11/07/2000US6143908 Process for preparation of 1,3-dioxolane-4-methanol compounds
11/07/2000US6143907 3-phenyl-1-methylenedioxyphenyl-indane-2-carboxylic acid derivatives
11/07/2000US6143790 Enzyme inhibitors
11/07/2000US6143787 Heterocyclic or aromatic oxoacids
11/07/2000US6143747 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
11/07/2000CA2083913C Piperazinyl-and piperidinyl-cyclohexanols
11/02/2000WO2000064848A1 Method for the dihydroxylation of olefins using transition-metal catalysts
11/02/2000WO2000064844A1 Method for the asymmetric dihydroxylation of olefins, using osmium catalysts
11/02/2000EP1048664A2 Process for the synthesis of 5-allybenzodioxoles
11/02/2000EP1047665A1 Matrix metalloprotease inhibitors
11/02/2000EP1047411A1 Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
11/02/2000CA2371186A1 Method for the asymmetric dihydroxylation of olefins, using osmium catalysts
11/02/2000CA2371183A1 Method for the dihydroxylation of olefins using transition-metal catalysts
11/01/2000CN1272107A Benzamidine derivatives as factor Xa inhibitors
11/01/2000CN1271732A Hypocrellin glycoside and its preparing process
10/2000
10/31/2000US6140505 Synthesis of benzo fused heterocyclic sulfonyl chlorides
10/31/2000US6140504 Substituted intermediate compounds for the preparation of n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
10/31/2000US6140353 Used as medicaments for the treatment and/or prevention of thromboses, apoplexy, cardiac infarction, inflammation and arteriosclerosis or as antitumor agents
10/31/2000US6140331 For treating anxiety disorders, depression, psychosis, impulse control disorders, alcohol abuse, ischaemic diseases, cardiovascular disorders, side effects induced by conventional antipsychotic agents and senile dementia
10/31/2000US6140330 Thiazole derivative
10/31/2000US6140026 Positive pattern images on substrates, coating a binder resin with photosensitive compound of o-quinonediazidesulfonic acid of phenol
10/26/2000DE19920039A1 Preparation of chiral 1,2-diols, useful as intermediates e.g. for pharmaceuticals, agrochemicals, cosmetics and chiral polymers, by hydroxylation of an olefin in the presence of oxygen, an osmium compound and a chiral amine
10/26/2000DE19920038A1 Preparation of 1,2-diols, used e.g. as a solvent or intermediate for polymers, agrochemicals, cosmetics and pharmaceuticals, by hydroxylation of an olefin in the presence of oxygen and an osmium, ruthenium or manganese compound
10/25/2000EP1046421A2 Methods and reagents for very large scale immobilized polymer synthesis
10/25/2000EP1045689A1 Synthesis of phenstatin and prodrugs thereof
10/25/2000CN1270955A Preparation of 1,5-di-o-coffeic acyl quininic acid derivative
10/25/2000CN1057763C Synthetic process of medicinal intermediate piperonyl amine
10/25/2000CN1057755C Fluoroalkenyl compounds and preparing method
10/24/2000US6136803 Cycloalkyl ether indanamine compounds
10/24/2000CA2157247C Physical form of dihydro-2,3-benzodiazepine derivative
10/19/2000WO2000061572A1 Diastereoselective preparation of michael adducts
10/19/2000DE19915601A1 3-Amino-3-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung 3-amino-3-arylpropan-1-ol-derivatives, their preparation and use
10/18/2000CN1270168A Magnolol series of compounds, synthesizing process thereof, and medicinal composition using same as active component
10/18/2000CN1270162A 3-amino-3-aryl-1-alcohol derivatives and preparation and use thereof
10/18/2000CN1057470C Ether isonitriles and radiolabeled complexes thereof
10/17/2000US6133442 For the treatment of disorders which are associated with endothelin activities, especially circulatory disorders such as hypertension, ischaemia, vasospasms and angina pectoris
10/17/2000US6133002 Acetalization of dialdehyde with alcohol, diol, or orthoformic ester; amination, cyanation, oxidation; enantioselective hydrolysis
10/12/2000WO2000059880A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/12/2000WO2000059868A1 Substituted aniline compounds
10/12/2000WO2000059506A1 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD
10/12/2000WO1993012754A3 Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors
10/12/2000CA2369238A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/12/2000CA2368703A1 Substituted aniline compounds
10/11/2000EP1043307A2 3-amino-3-arylpropan-1-ol-derivates, their preparation and their use
10/11/2000EP1042841A1 Non-aqueous electrolyte for electrochemical systems and lithium secondary battery comprising the same
10/11/2000EP1042280A2 Prodrugs of aspartyl protease inhibitors
10/11/2000EP1042279A1 Substituted beta-alanines
10/11/2000EP1042276A1 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
10/11/2000EP1041980A1 Acyl guanidine sodium/proton exchange inhibitors and method
10/11/2000CN1269775A Enantioselective reduction of ketones with silane agent/metal compound/chiral ligand system
10/11/2000CN1269136A Fluoric alkenyl compound and use as insect repellent agent
10/10/2000US6130354 Process for the preparation of shikimic acid and its derivatives
10/10/2000US6130226 Immunotherapeutic agents
10/07/2000CA2304127A1 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use
10/05/2000WO2000058288A1 Pyridine-2,3-dicarboxylic acid diamides
10/05/2000CA2368451A1 Pyridine-2,3-dicarboxylic acid diamides
10/04/2000EP1041072A1 Dioxocyclopentyl hydroxamic acids
10/04/2000EP1040103A1 Anilide derivative, production and use thereof
10/04/2000EP1040095A1 Cyclohexene carboxylates as neuraminidase inhibitors
10/04/2000EP1039897A1 Inadone and tetralone compounds for inhibiting cell proliferation
10/04/2000EP0766672B1 Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors
10/04/2000EP0765311B1 4-aryl-1-(indanmethyl, dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl)piperidines, tetrahydropyridines or piperazines
10/03/2000US6127556 Flowing protected aminoaldehyde into mixing zone maintained at low temperature, also flowing halomethyl organometallic reagent in said mixing zone and withdrawing the aminoepoxide reaction product; intermediate to hiv protease inhibitors
10/03/2000US6127537 Method for preparing 3-amino-1,2-propandiol derivatives
10/03/2000US6127415 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents
10/03/2000US6127372 Sulfonamide inhibitors of aspartyl protease
10/03/2000US6127364 Anthelminthics, insecticides, acaricides, and nematicides.
10/03/2000US6127189 Compositions and methods for detection of an amine compound in a fingerprint
09/2000
09/28/2000WO2000056694A1 Process for producing fluorine compound through liquid-phase fluorination
09/28/2000WO2000056681A1 Thiourea and urea liquid-phase combinatorial libraries: synthesis and apoptosis induction
09/28/2000WO2000003981A3 Preparation of (s)-2-amino-6,6-dimethoxyhexanoic acid methyl ester via novel dioxolanes
09/28/2000CA2367857A1 Thiourea and urea liquid-phase combinatorial libraries: synthesis and apoptosis induction
09/27/2000EP1037637A1 Use of 5ht1a receptor antagonists for preventing and/or treating temporal lobe epilepsy
09/27/2000CN1268117A Novel inhibitors of aggrecanase and matrix metalloproteinases for the treatment of arthritis
09/26/2000US6124479 Process for the preparation of 1,3-dioxolane-4-methanols
09/26/2000US6124354 Arylcycloalkane carboxylic esters, their use, pharmaceutical compositions and preparation
09/26/2000US6124343 For treating a patient subject to a disease state associated with a physiological detrimental excess of endothelin or a disease state associated with a pathological condition that is modulated by inhibiting endothelin
09/26/2000US6124102 Methods for determining receptor-ligand binding using probe arrays
09/21/2000WO2000055126A2 N-cyanomethylamides as protease inhibitors
09/21/2000WO2000055125A2 N-cyanomethyl amides as protease inhibitors
09/21/2000CA2368148A1 Novel compounds and compositions as protease inhibitors
09/21/2000CA2368122A1 Novel compounds and compositions as protease inhibitors
09/20/2000EP0705816B1 Benzene derivative useful for ischemic diseases
09/20/2000CN1267281A Glucagon antagonists/inverse agonists
09/19/2000US6121477 Enkephalinase inhibitors; enantiomorphs
09/19/2000US6121468 Process for producing amide derivatives and intermediate compounds
09/19/2000US6121322 Antiinflammatory agents
09/19/2000US6121316 2-cyano-3,5-dihydroxyhex-2-enecarboxamide derivatives
09/19/2000US6121304 Pentafluorobenzenesulfonamides and analogs
09/19/2000US6121281 Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use
09/19/2000US6121279 Phosphodiesterase inhibitor for treating respiratory system disorders
09/19/2000US6121026 Enantioselective bioreduction using yeast
09/14/2000WO2000053547A1 Method of preparing surface-active alcohols and surface-active alcoholic ethers, products obtained by said method and their use
09/14/2000DE19910370A1 Verfahren zur Herstellung von Tensidalkoholen und Tensidalkoholethern, die hergestellten Produkte und ihre Verwendung A process for the preparation of surfactant alcohols and surfactant alcohol ethers, the manufactured products and their use
1 ... 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 ... 183